SCHEMBL2321782

SCHEMBL2321782

CC(O[Sn](C(F)C(F)(F)C(F)(F)C(F)F)(C(F)C(F)(F)C(F)(F)C(F)F)C(F)C(F)(F)C(F)(F)C(F)F)c1ccccc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 1/20 0.32
HCAR2 Q8TDS4 1/20 0.31
CACNA1F O60840 1/20 0.30
CHRM2 P08172 1/20 0.30
CHRM1 P11229 1/20 0.30
ADRA2B P18089 1/20 0.30
CHRM3 P20309 1/20 0.30
ADRA1A P35348 1/20 0.30
HRH1 P35367 1/20 0.30
OPRK1 P41145 1/20 0.30
CACNA1D Q01668 1/20 0.30
SLC6A3 Q01959 1/20 0.30
KCNH2 Q12809 1/20 0.30
CACNA1S Q13698 1/20 0.30
CACNA1C Q13936 1/20 0.30
SCN5A Q14524 1/20 0.30
SLC6A4 P31645 1/20 0.30
MEN1 O00255 1/20 0.30
USP2 O75604 1/20 0.30
TP53 P04637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2326013 0.70 TAAR1 (0.33) HCAR2ADRA2B
SCHEMBL2341570 0.70 TACR1 (0.34) TACR1HCAR2
SCHEMBL2331798 0.69 TSHR (0.36) MEN1USP2TP53POLBMAPT
SCHEMBL2331962 0.69 HCAR2 (0.33) TACR1HCAR2
SCHEMBL2323305 0.68 LMNA (0.35) TACR1HCAR2MEN1POLBKMT2A
SCHEMBL2330109 0.67 HCAR2 (0.40) HCAR2CHRM2CHRM1ADRA2BADRA1A
SCHEMBL2697119 0.67 HCAR2 (0.40) HCAR2CHRM2CHRM1ADRA2BADRA1A
SCHEMBL2341010 0.66 TACR1 (0.33) TACR1MEN1POLBKMT2A
SCHEMBL2324889 0.66 TACR1 (0.33) TACR1HCAR2CHRM2ADRA2BADRA1A
SCHEMBL7851156 0.65 TACR1 (0.39) TACR1HCAR2CHRM2CHRM1ADRA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1987881-B1 METHOD FOR SEPARATION AND COLLECTION OF DIALKYL TIN DIALKOXIDE ASAHI KASEI CHEMICALS CORP (JP) 2011-08-17 EP disclosed
US-7842828-B2 Method for separating out and recovering dialkyltin dialkoxide ASAHI KASEI CHEMICALS CORPORATION (JP) 2010-11-30 US disclosed
US-20100160662-A1 Method for Separating Out and Recovering Dialkyltin Dialkoxide ASAHI KASEI KABUSHIKI KAISHA (JP) 2010-06-24 US disclosed
EP-1987881-A1 METHOD FOR SEPARATION AND COLLECTION OF DIALKYL TIN DIALKOXIDE Asahi Kasei Chemicals Corporation (JP) 2008-11-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160662-A1 Method for Separating Out and Recovering Dialkyltin Dialkoxide ALOX5, ALOX15B, ALOX15 TACR1 2330/4885HCAR2 861/4885CACNA1F 3623/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.